Rotterdam, Netherlands

Cock M Van Duijn


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cock M Van Duijn: Innovator in Hemochromatosis Research

Introduction

Cock M Van Duijn is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of genetics and medicine, particularly in the study of hemochromatosis. His work focuses on understanding the genetic mutations that lead to this condition and developing diagnostic and therapeutic methods.

Latest Patents

Cock M Van Duijn holds a patent for "Diagnostics and therapeutics for autosomal dominant hemochromatosis." This invention addresses the gene and mutations responsible for hemochromatosis (HH). Specifically, it highlights the presence of mutations on the ferroportin 1 (SLC11A3) gene, which results in abnormal iron transport. The patent also encompasses methods for creating diagnostic tools, drugs, and therapies aimed at treating patients with HH or anemia.

Career Highlights

Cock M Van Duijn is affiliated with Erasmus University Rotterdam, where he conducts his research. His work has been instrumental in advancing the understanding of genetic disorders and their implications for patient care. His innovative approach has paved the way for new treatment options for those affected by hemochromatosis.

Collaborations

Cock M Van Duijn has collaborated with esteemed colleagues, including Peter Heutink and Ben A Oostra. These partnerships have enhanced the research efforts in the field of genetics and have contributed to the development of effective therapeutic strategies.

Conclusion

Cock M Van Duijn's contributions to the field of hemochromatosis research exemplify the impact of innovation in medicine. His work not only furthers scientific understanding but also holds promise for improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…